E2 ModeratePreliminaryPEM not requiredCross-SectionalPeer-reviewedMachine draft
The immune checkpoint pathophysiology of depression and chronic fatigue syndrome due to preeclampsia: focus on sCD80 and sCTLA-4.
Omar, Jangir Sami, Albarzinji, Niaz, Niu, Mengqi et al. · Acta neuropsychiatrica · 2025 · DOI
Quick Summary
This study looked at immune system markers in pregnant women with preeclampsia (a serious pregnancy condition) who also experienced depression, anxiety, and fatigue. Researchers found that certain immune molecules called sCTLA-4 and sCD80, along with imbalances in minerals like zinc and magnesium, were associated with these neuropsychiatric symptoms. The study suggests that immune system activation may play a role in why preeclampsia causes mood and fatigue problems.
Why It Matters
Understanding immune checkpoint dysregulation in fatigue and mood symptoms may provide insight into mechanisms shared between preeclampsia-associated neuropsychiatric manifestations and ME/CFS. The identification of specific immune molecules and micronutrient imbalances offers potential therapeutic targets and biomarkers that could be investigated in ME/CFS cohorts.
Observed Findings
- PE women showed higher depression (HAMD), anxiety (HAMA), and fibro-fatigue (FF) rating scale scores compared to controls.
- Serum sCTLA-4, sCD80, and copper were significantly elevated in PE women; zinc, magnesium, and calcium were significantly lower.
- Biomarker profiles explained 55.8–58.0% of the variance in depression, anxiety, and fatigue scores.
- The sCTLA-4/sCD80 ratio showed significant inverse correlation with HAMD, HAMA, and FF scores.
- sCTLA-4, vitamin D, calcium, and copper together explained approximately 70% of variance in systolic blood pressure.
Inferred Conclusions
- Preeclampsia-associated neuropsychiatric symptoms (depression, anxiety, chronic fatigue) are accompanied by activation of immune-inflammatory pathways involving soluble checkpoint molecules.
- Disbalances in immune checkpoint molecules (particularly the sCTLA-4/sCD80 ratio) and micronutrient status are involved in both hypertension and neuropsychiatric manifestations in PE.
- Immune checkpoint dysregulation may represent a shared pathophysiological mechanism linking hypertension, mood disorders, and fatigue in preeclampsia.
Remaining Questions
- Do sCTLA-4 and sCD80 imbalances directly cause neuropsychiatric symptoms or are they secondary markers of broader immune dysregulation?
What This Study Does Not Prove
This study does not prove that sCTLA-4 and sCD80 imbalances *cause* depression, anxiety, or fatigue—only that they are associated. The findings are specific to pregnant women with preeclampsia and cannot be directly applied to ME/CFS patients without independent validation. Cross-sectional design cannot establish temporal or causal relationships.
Tags
Symptom:Fatigue
Biomarker:CytokinesBlood Biomarker
Method Flag:Small SampleExploratory OnlyMixed Cohort
Metadata
- DOI
- 10.1017/neu.2025.10
- PMID
- 40130935
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →